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Highlights from this short review include: 
 the comet assay in assessing genomic stability in relation to folate status and human cancer 
 impact of folate deficiency/supplementation on genomic stability in vitro, in rodents and 
humans 
 the impact of MTHFR genotype on folate status and genomic stability in human carcinogenesis  
 adaptation of the comet assay in measuring DNA methylation and impact on diet and 
epigenetics 
 
 
Abstract 
 
Intake of folate (vitamin B9) is strongly inversely linked with human cancer risk, particularly 
colon cancer. In general, people with the highest dietary intake of folate or with high blood 
folate levels are at a reduced risk (approx. 25%) of developing colon cancer.  
Folate acts in normal cellular metabolism to maintain genomic stability through the provision 
of nucleotides for DNA replication and DNA repair and by regulating DNA methylation and 
gene expression. Folate deficiency can accelerate carcinogenesis by inducing 
misincorporation of uracil into DNA, by increasing DNA strand breakage, by inhibiting DNA 
base excision repair capacity and by inducing DNA hypomethylation and consequently 
aberrant gene and protein expression. Conversely, increasing folate intake may improve 
genomic stability. 
 
This review describes key applications of single cell gel electrophoresis (the comet assay) in 
assessing genomic instability (misincorporated uracil, DNA single strand breakage and DNA 
repair capacity) in response to folate status (deficient or supplemented) in human cells in 
vitro, in rodent models and in human case-control and intervention studies. It highlights an 
adaptation of the SCGE comet assay for measuring genome-wide and gene-specific DNA 
methylation in human cells and colon tissue. 
 
Keywords: single cell gel electrophoresis, comet assay, folate, genomic stability, colon, uracil, 
DNA methylation 
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1. Introduction 
Single cell gel electrophoresis (SCGE) or the comet assay is now established in human 
biomonitoring as a sensitive and specific assay capable of measuring low levels of DNA strand 
breakage, altered DNA bases and DNA repair capacity in human populations. However, the 
comet assay is also a particularly valuable investigative tool for exploring experimental 
mechanisms of genotoxicity linked to genomic instability, malignant transformation and 
carcinogenesis.  
Intake of vitamin B9 (folate) is strongly linked with human cancer risk [1-4]. This review 
describes several important modifications of the comet assay for assessing DNA instability in 
response to folate status in human cells in vitro, in rats in vivo and in human studies, and 
highlights an emerging application of the SCGE assay in measuring aberrant DNA methylation. 
 
2. Folate status and human cancers 
Folates, a family of water-soluble B vitamins are found in a wide variety of foods including 
green leafy vegetables, cereals, beans, fruit and liver, and play a crucial role in preventing the 
development of human pathologies such as cancer and heart disease in adults, cognitive 
dysfunction and dementia in the elderly and congenital defects in babies. In the UK, 
suboptimal folate status is common, particularly in adolescents and the elderly. Overt folate 
deficiency has been implicated in the development of several human malignancies including 
cancer of the breast, ovary, lung and cervix [1,2]. Moreover, the evidence linking low folate 
status with an increased risk of colon cancer (CC) is particularly strong [1,2]. Globally, CC is 
the 3rd most commonly diagnosed cancer in the world (http://globocan.iarc.fr). Recent meta-
analyses of case-control and prospective studies consistently report a reduced relative risk 
(RR) for CC in people with a high dietary folate intake compared with people with a low intake: 
RR 0.75; 95% CI=0.64-0.89 [3]; RR 0.81; 95% CI=0.66-0.99 [4]. 
 
3. Folate and mechanisms of carcinogenesis 
Folate is critical in one-carbon metabolism and acts to maintain genomic stability by 
regulating DNA biosynthesis and DNA repair and by controlling DNA methylation and gene 
expression (Figure 1). Within the methionine cycle, 5-methyltetrahydrofolate (5-methylTHF) 
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remethylates homocysteine to methionine, which is further metabolised to S-
adenosylmethionine (SAM). SAM controls gene transcription and ultimately protein 
expression through its ability to methylate cytosine in the DNA molecule. Similarly, folate is 
essential for the synthesis of both purines and the pyrimidine nucleoside thymidine. 
Deoxyuridine monophosphate (dUMP) is converted to deoxythymidine monophosphate 
(dTMP) by thymidylate synthase (TS), using 5,10-methylenetetrahydrofolate (5,10-
methyleneTHF) as methyl donor. Subsequently, 5,10-formyltetrahydrofolate (5,10-
formylTHF) is involved in the production of both adenosine and guanosine. Continual 
production of these DNA precursors is essential for normal DNA synthesis and for effective 
DNA repair. Folate insufficiency induces and accelerates carcinogenesis by perturbing each of 
these processes [1,2]. If dietary folate is limiting, the balance of purine and pyrimidine DNA 
precursors is altered and normal DNA synthesis and DNA repair are inhibited, leading to 
mutagenesis and malignant transformation. Moreover, folate depletion blocks the normal 
methylation of dUMP to dTMP, ultimately causing an accumulation of deoxyuridine 
triphosphate (dUTP). As dUTP and deoxythymidine triphosphate (dTTP) differ only by a single 
methyl group, the RNA base uracil, which is not normally present in DNA, is misincorporated 
into the DNA molecule in place of thymine (Figure 2). This mismatch quickly triggers DNA base 
excision repair (BER) processes that remove the uracil from the DNA. However, if folate 
availability continually limits the synthesis of thymine, then uracil is misincorporated and 
cleaved from the DNA in what is described as “a catastrophic repair cycle”, resulting in DNA 
double strand breakage, chromosomal damage and ultimately malignant transformation [5]. 
Folate deficiency similarly perturbs the production of S-adenosylmethionine (SAM; Figure 3), 
causing a reduction in the normal methylation of cytosine in the DNA molecule and leading 
to global DNA hypomethylation and inappropriate proto-oncogene activation [6,7]. This will 
be addressed in detail later in this review. 
 
4. Using SCGE to understand the impact of folate status on genomic stability 
 
4.1. Misincorporated uracil 
As described above, folate deficiency induces misincorporation of uracil into DNA, 
subsequently inducing DNA single and double strand breakage and ultimately chromosomal 
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damage and malignant transformation [1,5]. A valuable modification of the alkaline comet 
assay has allowed for uracil to be detected and measured specifically in human and animal 
cells and tissues. Here, DNA nucleoids are lysed and incubated with the bacterial DNA repair 
enzyme uracil DNA glycosylase (UDG; 1 unit/g DNA for 30 min) which removes 
misincorporated uracil from the DNA molecule, leaving a single strand break which is detected 
by the comet assay in the standard manner [8]. This assay, specifically developed to measure 
uracil misincorporation, has been employed in the study of human peripheral blood 
mononuclear cells (PBMC), epithelial cells and colonocytes in vitro [8-10], in rodent studies 
[11,12] and in both human observational and intervention studies [13,14] to determine the 
influence of folate status on DNA stability. 
Growing human cells in folate-free medium inhibits DNA synthesis and progressively 
increases uracil misincorporation (2-3-fold) in PBMC ex vivo [9], in human colonocytes [15], 
and in SV40-immortalised human colon epithelial cells (HCEC) with time in culture [10]. This 
detrimental effect of folate deficiency on DNA stability in HCEC was highly sensitive to folate, 
with uracil concentrations declining to baseline levels after repleting the cells with folate at 
concentrations normally observed in both human blood and colon tissue (10 ng/mL; [10]). 
Nutritional folate deficiency has also been shown to induce DNA instability in rodents in vivo. 
Here, DNA uracil misincorporation and DNA single strand breakage increased 2-fold (P<0.001) 
in PBMC isolated from male Rowett Hooded Lister rats fed a folate-free diet either for 10 or 
24 weeks [11,12]. However, the modified comet assay is probably most valuable when 
deployed in biomonitoring to understand better the relationship between folate and DNA 
stability in humans.  
While elevated uracil misincorporation has been measured [by gas chromatography mass 
spectrometry (GC MS) or the highly invasive deoxurydine assay] in PBMC and bone marrow 
from patients with severe folate deficiency and/or megaloblastic anaemia [5,16], little work 
has been carried out to establish whether there may be a beneficial effect on DNA stability by 
improving folate status in the general population. Supplementing apparently healthy men 
(n=15) and women (N=15) (mean age 41 years old with a red blood cell folate level of 250-
650 nmol/L) with folic acid (1.2 mg/day) for 12 weeks substantially increased red blood cell 
folate (approx. 90%; P<0.01), PBMC folate (approx. 85%; P<0.01) and plasma 5-methylTHF 
(approx. 300%; P<0.01), when compared with participants taking placebo [17]. Low levels of 
uracil were detected using SCGE in the PBMC of these healthy participants, and this strongly 
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correlated with PBMC folate (Figure 4; r= -0.49, P<0.01), plasma 5-methylTHF (r= -0.48, 
P<0.01) and intracellular red cell folate status (r= -0.46, P<0.01) both pre- and post-
intervention. Moreover, increasing blood folate concentration decreased significantly the 
level of uracil measured in PBMC isolated from subjects in the intervention group (approx. 
20%, P<0.05), highlighting that genomic stability can be improved by increasing folate levels 
even in folate-sufficient subjects [14,17]. However, the majority of human biomonitoring 
studies are (necessarily) limited in that they measure genomic stability in blood cells rather 
than in the target organ.  Nonetheless, a few studies have determined the direct impact of 
folate status on genomic stability and specifically uracil misincorporation in the colon.  In a 
study of patients with adenomatous (n=40) or hyperplastic polyps (n=16), folate levels in 
colon biopsy samples decreased (as much as 25%) with proximity to the polyp site when 
compared with control subjects (n=53). Moreover, there was a corresponding increase in 
misincorporated uracil (measured using the UDG-modified comet assay) [18]. In a follow-up 
intervention study by the same research group [19], uracil misincorporation ratio (UDG-
modified comet assay) declined by 0.5 (P<0.05) at the site closest to the original polyp in 
polypectomised patients following treatment with folic acid (600 g/day) for six months.  
These findings show that uracil misincorporation is responsive to folate status both in 
surrogate and target tissue. 
 
4.2. DNA strand breakage, DNA repair capacity and apoptosis 
There are currently two ways in which the comet assay is used to measure DNA BER; the 
cellular repair assay, where whole cells are exposed in culture to a model damaging agent and 
complete repair of DNA strand breaks or DNA lesions is followed with time; and the in vitro 
cell-free repair assay where repair enzymes in a prepared cell extract (normally PBMC) incise 
model substrate DNA that contains an induced and specific lesion. Both of these assays have 
been used to assess how folate status affects DNA BER activity. 
DNA BER capacity (cellular assay) is inhibited in folate-depleted human PBMC ex vivo and in 
SV40-immortalised HCEC in response to both oxidative (hydrogen peroxide) and alkylation 
(methyl-methane-sulfonate) damage [9,10].  
A similar effect has been observed in non-transfected normal human colon epithelial cells. 
Originally isolated from a 68 year old Hispanic male, NCM460 cells (obtained under a material 
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transfer agreement from INCELL, San Antonio USA) have been used to model B vitamin uptake 
and metabolism in the human intestine [20] and to assess the effect of folate deficiency on 
genomic stability [15].  The experiment described below demonstrates how folate depletion 
alters endogenous DNA strand breakage, DNA BER activity (measured using the comet assay), 
and ultimately apoptosis, in non-tumour derived human colon cells.  
NCM460 cells were grown in A52 medium (BioConcept, Switzerland) in the absence (F-) or 
presence of folic acid (F+; 4 g/mL). Intracellular total folate (measured by radioassay; [15]), 
cell proliferation (cell number), endogenous DNA strand breakage (comet assay), DNA BER 
capacity (comet assay) and apoptosis [polycaspase (1,3,4-9) activity using Vibrant FAM 
polycaspase assay kit (Invitrogen, UK) and by Flow cytometry (4 colour FACS Calibur, Becton 
Dickinson, Oxford, UK)] were measured up to 15 days in culture.  
Intracellular total folate was depleted by more than 90% in NCM460 cells cultured in the 
absence of folic acid while cell growth was progressively inhibited to approx. 33% of the levels 
observed in folate supplemented cultures after 15 days (data not shown). Folate depletion 
induced genomic instability in normal human colonocytes, observed as a progressive increase 
in endogenous DNA strand breakage (Figure 5) and inhibition of DNA BER capacity (Figure 6) 
in response to oxidative challenge (20 M H2O2). In this experiment, DNA strand breaks 
increased more than 2-fold [69.3 compared with 32.1 AU in F- versus F+ NCM460 cells 
respectively (P<0.01)] and BER rate was approx. 17% lower in folate depleted NCM460 after 
14 days [3.67 compared with 4.43 AU/min respectively (P<0.05)]. Additionally, this time-
dependent decrease in genomic stability as a consequence of folate depletion, translated into 
increased programmed cell death. 
Caspase activation is used as an initial marker for the induction of programmed cell death 
such as results from folate depletion. Caspases are a family of cysteine proteases linked to 
programmed cell death events, and in particular to the development and execution of 
apoptosis [21]. Apoptosis is intimately linked to maintaining genomic stability by removal of 
damaged cells, thereby reducing the risk of malignant transformation leading to 
tumorigenesis.  
While folate deficiency was initially associated with a small decrease in polycaspase activation 
as detected by flow cytometric analysis using the vibrant FAM polycaspase assay (which 
identifies the majority of caspase activies including caspase-1, 2, 4, 5, 7 and 9) in human 
colonocytes, this was followed by a substantial increase (approx. 50%) in enzyme activity after 
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14 days in culture (Figure 7A). This elevation was observed without any concomitant change 
in colonocyte cell membrane integrity (as measured by propidium iodide uptake), indicating 
the likelihood of an apoptotic rather than necrotic mechanism of cell death (Figure 7B). These 
data confirm that folate deficiency detrimentally impacts on genomic stability in normal 
human colon epithelial cells, by inducing DNA strand breakage and concurrently inhibiting 
effective DNA repair, resulting in an increased activity linked to elimination of critically 
damaged colonocytes from the population. 
We have also shown that BER capacity is sensitive to folate status in humans. In the human 
intervention study described above, BER repair capacity in participants receiving a folic acid 
supplement (1.2 mg daily for 12 weeks) or control participants was measured by employing 
the cell-free DNA BER comet assay. Extracts were prepared from PBMC sampled from the 
participants at the start and at the end of the study. Excision repair capacity was measured as 
the ability of PBMC extracts to excise 8-oxo-7,8-dihyroguanine (8-oxodG) from Chinese 
hamster Ovary (CHO) DNA over 20 min following exposure to the model sensitiser RO19-8022 
[14]. Excision of 8-oxodG leaves a strand break, which is measured using the conventional 
alkaline comet assay. Increasing folate concntration in the majority of these normal healthy 
study participants had no significant effect on BER capacity. However, folate supplementation 
significantly reduced incision repair activity in those subjects with the lowest initial baseline 
red cell folate levels suggesting either that increased provision of DNA nucleotides or a 
reduction in DNA damage, may downregulate BER capacity only in relatively folate-depleted 
individuals [14]. 
 
5. The impact of nutrient-gene interactions on folate metabolism and genomic stability 
An important but relatively neglected area of investigation pertaining to folate status and 
cancer risk is the impact of nutrient:gene interactions on genomic stability. The enzyme 
methylenetetrahydrofolate reductase (MTHFR; EC 1.5.1.20), which irreversibly converts 5,10-
methyleneTHF to 5-methylTHF (Figure 1), is a pivotal protein in folate metabolism which, 
when functional, directs methyl groups away from the production of thymidine towards 
homocysteine remethylation and the production of SAM. Two human polymorphisms in 
MTHFR (C677T and A1298C) are associated with a reduced enzyme activity, low circulating 
folate, low SAM and elevated homocysteine levels. Given that low SAM would result in an 
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increased likelihood of DNA hypomethylation, and contrary to what might be expected, these 
variants are actually associated with a reduced risk of CC [22]. One hypothesis is that the 
homozygous recessive variant reduces genomic instability by ensuring the continual 
production of nucleotides for DNA synthesis and repair (Figure 1). In a study of 199 individuals 
without cancer, homozygosity for the C677T polymorphism was associated with a reduced 
plasma and red cell folate (both approx. 25%) level, and decreased hyper-homocysteinemia 
(approx. 21%) when compared with wild type individuals. However, DNA strand breakage and 
uracil misincorporation (both measured by SCGE) were similar for all genotypes, indicating 
that in this study sequestration of 5,10-methyleneTHF for thymidine synthesis was not a 
major contributor to the apparent enhanced genomic stability in C677TT homozygous 
variants [13]. Nonetheless, other groups have found a lower level of plasma folate and of 
misincorporated uracil (measured in leukocytes using the uracil DNA glycosylase-modified 
comet assay) in individuals carrying the C677T polymorphism [23]. However, this study is 
limited by both the small sample size (n=14) and the need to combine data for the C677CT 
and 677TT genotypes for the analyses. 
 
6. Innovations in the comet assay to detect DNA methylation 
While the comet assay is now used widely to investigate the influence of folate on DNA repair 
capacity and genomic stability, new variations are being developed to improve further the 
specificity and effectiveness of the assay in establishing folate-modulated mechanisms of 
carcinogenesis.  
It is now established that epigenetic changes, including aberrant DNA methylation, play a 
critical role in human carcinogenesis [24]. Moreover, it is estimated that dysregulated DNA 
methylation is involved in the aetiology of approx. one fifth of all CC cancer cases [25].  
Folate (5-methylTHF) plays a critical role in the normal regulation of gene and protein 
expression by acting as methyl donor for the methylation of cytosines in the DNA molecule. 
Folate deficiency disrupts normal DNA methylation by attenuating the remethylation of SAH 
to SAM and inducing DNA hypomethylation in newly synthesised DNA. This effectively allows 
for the inappropriate expression (or over-expression) of genes, including proto-oncogenes, 
that increase the risk of malignant transformation and cancer [7; Figure 3]. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
10 
Methods for measuring genomic DNA methylation, which include Southern blotting, liquid 
chromatography tandem mass spectrometry (LCMSMS/MS) and a nucleotide extension 
assay, are expensive, require considerable biological material and can provide inconsistent 
data. As aberrant DNA methylation plays a role in both the early development of CC (global 
hypomethylation) and in advanced stages of tumours (gene-specific hypermethylation), the 
ability to detect and quantify aberrant methylation from blood samples or small tumour 
biopsies would offer a valuable predictive and prognostic biomarker. A methyl-sensitive 
variation of the SCGE assay has been described previously. This assay compared with other 
methods is simpler and more cost-effective [26-29]. For this modification, two isoschizomer 
endonucleases (HpaII and MspI) that share the same restriction site in CpG islands are 
deployed separately in the assay at the post-lysis step. As only HpaII activity is blocked by 
methylation in the restriction site, the level of HpaII digestion is inversely proportional to the 
level of global DNA methylation. Thus, global methylation changes can be evaluated as the 
ratio between the comet scores after the two separate enzymic digestions. 
We have developed this method further and tested its ability to detect perturbations in DNA 
methylation in human colon cells as a consequence of folate depletion (hypomethylation) or 
exposure to nickel chloride which has been shown to induce DNA hypermethylation [28]. 
To induce a state of DNA hypomethylation, NCM460 human colon epithelial cells (cultured in 
A52 medium as described previously) or primary human colon fibroblasts [CCD-18Co obtained 
from the American Type Culture Collection and cultured in DMEM with low glucose (1.0 g/L)] 
were grown for 48h, or 7 days, either in regular culture medium containing folic acid (4 g/mL) 
or in the same medium without folic acid (BioConcept Inc, Switzerland). To induce DNA 
hypermethylation, colonocytes and fibroblasts in folate sufficient medium were exposed to 
NiCl2 (500 M) for 24h.  SCGE was carried out essentially as described previously with the 
subsequent addition of a fast digest endonuclease enzyme incubation step [27]. Post lysis, the 
slides were washed three times for 5 min each with PBS (4oC) before incubation either with 
HpaII, MspI or Fast Digest Buffer [FDB; (ThermoFisher Scientific Inc, Massachusetts, USA] in a 
humidified chamber at 37oC for 15 min. At the end of this incubation, the slides were 
subjected to alkaline unwinding (40 min), electrophoresis (40 min), staining (DAPI 1 g/mL) 
and visual scoring as normal [30].  
Genome-wide DNA methylation was calculated as the ratio between the two separate 
enzyme digestions after accounting for the effect of buffer alone [28], with a higher ratio 
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reflecting a lower level of DNA methylation. NiCl2 induced DNA hypermethylation in both 
human colon cell lines (Figure 8A). However, the effect was statistically significant only in CCD-
18Co fibroblasts. Short-term folate depletion (48h) increased the HpaII/MspI ratio approx. 3-
fold for the epithelial and 4-fold for the colon fibroblast cells (Figure 8B), indicating that HpaII 
digestion was, as expected, more effective, when DNA methylation is lower. A similar result 
was observed after 7 days in response to longer-term folate deficiency (Figure 8B).  
These data indicate that this modification of the comet assay to detect DNA methylation in 
single cells is responsive to known modifiers of methylation status. Similar results have been 
reported using another methylation-sensitive variant of the comet assay [31]. Here DNA 
methylation status was measured by SCGE in folate deficient or replete human colonic 
adenocarcinoma SW620 cells (up to 14 days) using the methylation-sensitive restriction 
enzymes HpaII and HhaI (2.5U/gel for 1h). DNA global hypomethylation increased significantly 
(approx.6-fold) in folate depleted cells. Moreover, there was also significant DNA 
hypomethylation detected in the p53 gene region in these cells (approx. 2-3 fold), measured 
using a particularly elegant variant of the methylation-sensitive comet assay, which combines 
SCGE and FISH [31]. 
In view of the role of aberrant DNA methylation in cancer development, the ability to adapt 
the comet assay to specifically detect changes in DNA methylation patterns in human tissue 
will undoubtedly advance understanding of how epigenetics influences human cancer risk. An 
initial application of a methylation-sensitive variant of the comet assay [31] in the context of 
human carcinogenesis demonstrated that folate levels are significantly lower in colon tissue 
biopsies from patients with pre-cancerous polyps  compared with non-diseased controls, and 
this is associated with genome-wide DNA hypomethylation [18]. Moreover, both colonocyte 
folate and DNA methylation declined with proximity to the original polyp site [18]. Global 
aberrant DNA methylation was found to be responsive to folate supplementation in a 
subsequent intervention study, which demonstrated that taking folic acid (600 g/day for 6 
months) decreased genome-wide DNA hypomethylation in colonocytes isolated from 
polypectomised patients (n=12) compared with non-supplemented individuals (n=8) [19].  
 
7. Summary 
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A considerable strength of SCGE is the genuine adaptability of the assay to measure multiple 
biomarkers of DNA stability. This review demonstrates that employing the comet assay to 
measure DNA strand breakage, misincorporated uracil, DNA BER capacity and now, DNA 
methylation in single cells, allows us to better understand in detail, how the B vitamin folate 
acts mechanistically on DNA stability and malignant transformation in human and rodent 
models. These studies serve to highlight the sensitivity of the assay to detect, and at least 
partially quantify, changes in DNA stability due to intervention. Here, we have been able to 
establish how folate deficiency works through increased uracil misincorporation, DNA strand 
breakage, defective BER and DNA hypomethylation to induce or accelerate genomic 
instability, while conversely, improved folate status reduces misincorporated uracil in 
patients with colon polyps and even in apparently healthy human volunteers.  
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Figure 1. Folate and one-carbon metabolism: regulation of DNA synthesis, DNA repair and 
DNA methylation. 
A simplified scheme showing how dietary and cellular folates mediate (A) normal DNA 
synthesis, and repair and (B) DNA methylation and gene expression  
Abbreviations: dihydrofolate: DHF; tetrahydrofolate: THF; 5,10-methylenetetrahydrofolate: 
5,10-methyleneTHF; 5,10-formyltetrahydrofolate: 5,10-formylTHF; 5-
methyltetrahydrofolate: 5-methylTHF; s-adenosylmethionine: SAM; s-
adenosylhomocysteine: SAH; methylenetetrahydrofolate reductase: MTHFR; deoxyuridine 
monophosphate: dUMP; deoxythymidine monophosphate: dTMP; thymidylate synthase: TS. 
Adapted with kind permission from J. Inherited & Metabolic Disorders [1]. 
 
Figure 2. Folate deficiency and uracil misincorporation  
The impact of dietary folate deficiency on uracil misincorporation and chromosomal 
instability. Abbreviations: dUTP: deoxyuridine triphosphate; dTTP: deoxythymidine 
triphosphate. Colon crypts by Nephron (Own work) [CC BY-SA 3.0 
(http://creativecommons.org/licenses/by-sa/3.0) or GFDL 
(http://www.gnu.org/copyleft/fdl.html)] via Wikimedia Commons. Images of DNA damage 
are authors own. 
 
Figure 3. Folate deficiency, aberrant DNA methylation and gene expression 
The effect of dietary folate deficiency on DNA hypomethylation and proto-oncogene 
expression. Abbreviations: 5-methyltetrahydrofolate: 5-methylTHF; s-adenosylmethionine: 
SAM; s-adenosylhomocysteine: SAH; DNAMT: DNA methyltransferase. Colon crypts by 
Nephron (Own work) [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0) or GFDL 
(http://www.gnu.org/copyleft/fdl.html)] via Wikimedia Commons.  
 
Figure 4. Association between PBMC folate status and PBMC DNA uracil 
misincorporation in volunteers 
Change in uracil misincorporation with increasing PBMC folate status due to intervention with 
folic acid (1.2mg/day for 12 weeks) in healthy human volunteers. Adapted with kind 
permission from the British Journal of Cancer [14]. 
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Figure 5. Effect of folic acid deficiency on endogenous DNA damage  
Endogenous DNA strand breakage in NCM460 cells cultured under folic acid sufficient (F+; 
4g/mL, black) or deficient (F-; <1 ng/mL, grey) conditions. Results are mean ± SEM (n=6). 
*p<0.01, where P values refer to differences between cells grown in the presence or absence 
of folate by Students T-test. 
 
Figure 6. Effect of folic acid deficiency on DNA base excision repair capacity (BER) with time. 
NCM460 cells were grown in the presence or absence of folic acid for 7 (A) or 14 days (B) in 
either folic acid sufficient (4 g/mL, ●) or deficient (<1 ng/mL, □) conditions. Cells were 
exposed to hydrogen peroxide (200g) and BER capacity measured over 60 min. UT; 
untreated cells. Results are mean ± SEM (n=6). *p<0.05, where P values refer to differences 
between cells grown in the presence or absence of folate by Students T-test. 
 
Figure 7. Effect of folic acid deficiency on caspase (A) and cell membrane integrity (B) 
Poly-caspase activation and cell membrane permeability was measured in NCM460 cells 
cultured under folic acid sufficient (F+; 4 g/ml, black) or deficient (F-; <1 ng/mL, grey) 
conditions for 7 or 14 days. Results are mean ± SEM (n>/=5). *p<0.05, **p<0.001, where P 
values refer to differences between cells grown in the presence or absence of folate by 
Students T-test. 
 
Figure 8: Global DNA methylation measured in human colon cells and fibroblasts 
The methylation-sensitive variant of the comet assay was used in NCM460 colon epithelial 
cells and CCD-18Co fibroblasts. (A) Effect of a hypermethylating stimulus: 500 M NiCl2 
treatment for 24h. (B) Effect of folic acid (FA) depletion for 48h or 7 days [F+ (4 g/ml) or F- 
(0 ng/mL)]. Results show the mean ratio between HpaII and MspI DNA digestion ± SE (n=4).  
*p<0.05 where P values refer to differences between treated and untreated cells by one-way 
ANOVA. 
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